C21H19N3O5
393.4 g/mol
APIWarning
Fruquintinib
CAS1194506-26-7
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Fruquintinib is an active pharmaceutical ingredient that functions as a kinase inhibitor. It is used in the manufacturing of medications for colorectal cancer and is administered orally.
Pharmaceutical raw material for kinase inhibitor drugsCompound used in colorectal cancer medication manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1194506-26-7
Related Compounds
ReferenceSame Category
Danofloxacin mesylate
CAS119478-55-6
pharmaceutical raw material
ReferenceSame Category
Meropenem trihydrate
CAS119478-56-7
pharmaceutical raw material
ReferenceSame Category
Zilpaterol hydrochloride
CAS119520-06-8
pharmaceutical raw material
ReferenceSame Category
Dabrafenib
CAS1195765-45-7
pharmaceutical raw material
Safety Reference
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
6-(6,7-dimethoxyquinazolin-4-yl)oxy-N,2-dimethyl-1-benzofuran-3-carboxamide
InChIKey
BALLNEJQLSTPIO-UHFFFAOYSA-N
SMILES
CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC
Synonyms (14)
- Fruquintinib (JAN/USAN)
- Elunate
- Fruquintinib
- Fruquintinib (Standard)
- Fruquintinib; HMPL-013
- Fruzaqla
- Fruzaqla (TN)
- HMPL 013
- fruquintinibum